Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

105 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Initial response and 12-month outcomes after commencing dexamethasone or vascular endothelial growth factor inhibitors for retinal vein occlusion in the FRB registry.
Garay-Aramburu G, Hunt A, Arruabarrena C, Mehta H, Invernizzi A, Gabrielle PH, Guillaumie T, Wolff B, Gillies MC, Zarranz-Ventura J. Garay-Aramburu G, et al. Among authors: zarranz ventura j. Sci Rep. 2024 Mar 13;14(1):6122. doi: 10.1038/s41598-024-56581-6. Sci Rep. 2024. PMID: 38480837 Free PMC article.
[Genetics and ARMD: from the laboratory to the consulting room].
García Layana A, Zarranz-Ventura J, Fernández Robredo P, Recalde S, Rodríguez de Córdoba S; Grupo Español de Investigación Cooperativa en DMAE. García Layana A, et al. Arch Soc Esp Oftalmol. 2011 Apr;86(4):101-2. doi: 10.1016/j.oftal.2011.03.005. Arch Soc Esp Oftalmol. 2011. PMID: 21569917 Spanish. No abstract available.
[Corneal manifestations in systemic diseases].
Zarranz Ventura J, De Nova E, Moreno-Montañés J. Zarranz Ventura J, et al. An Sist Sanit Navar. 2008;31 Suppl 3:155-70. An Sist Sanit Navar. 2008. PMID: 19169303 Free article. Review. Spanish.
Safety of 6000 intravitreal dexamethasone implants.
Rajesh B, Zarranz-Ventura J, Fung AT, Busch C, Sahoo NK, Rodriguez-Valdes PJ, Sarao V, Mishra SK, Saatci AO, Udaondo Mirete P, Querques G, Farah ME, Lanzetta P, Arevalo JF, Kodjikian L, Chhablani J; for International Ozurdex Study Group. Rajesh B, et al. Br J Ophthalmol. 2020 Jan;104(1):39-46. doi: 10.1136/bjophthalmol-2019-313991. Epub 2019 Apr 30. Br J Ophthalmol. 2020. PMID: 31040132
Treat-and-extend versus fixed bimonthly treatment regimens for treatment-naive neovascular age-related macular degeneration: real world data from the Fight Retinal Blindness registry.
Figueras-Roca M, Parrado-Carrillo A, Nguyen V, Casaroli-Marano RP, Moll-Udina A, Gillies MC, Barthelmes D, Zarranz-Ventura J. Figueras-Roca M, et al. Graefes Arch Clin Exp Ophthalmol. 2021 Jun;259(6):1463-1470. doi: 10.1007/s00417-020-05016-9. Epub 2020 Nov 20. Graefes Arch Clin Exp Ophthalmol. 2021. PMID: 33219442
Twelve-month outcomes of ranibizumab versus aflibercept for macular oedema in branch retinal vein occlusion: data from the FRB! registry.
Hunt AR, Nguyen V, Creuzot-Garcher CP, Alforja S, Gabrielle PH, Zarranz-Ventura J, Guillemin M, Fraser-Bell S, Casaroli Marano RP, Arnold J, McAllister IL, O'Toole L, Gillies MC, Barthelmes D, Mehta H. Hunt AR, et al. Br J Ophthalmol. 2022 Aug;106(8):1178-1184. doi: 10.1136/bjophthalmol-2020-318491. Epub 2021 Mar 12. Br J Ophthalmol. 2022. PMID: 33712484
105 results